BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35587492)

  • 21. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and potential methods for second trimester abortion.
    Lerma K; Blumenthal PD
    Best Pract Res Clin Obstet Gynaecol; 2020 Feb; 63():24-36. PubMed ID: 31281014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation.
    Osur J; Baird TL; Levandowski BA; Jackson E; Murokora D
    Glob Health Action; 2013 Apr; 6():1-11. PubMed ID: 23618341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.
    Lince-Deroche N; Constant D; Harries J; Kluge J; Blanchard K; Sinanovic E; Grossman D
    PLoS One; 2018; 13(6):e0197485. PubMed ID: 29953434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's Acceptability of Misoprostol Treatment for Incomplete Abortion by Midwives and Physicians - Secondary Outcome Analysis from a Randomized Controlled Equivalence Trial at District Level in Uganda.
    Cleeve A; Byamugisha J; Gemzell-Danielsson K; Mbona Tumwesigye N; Atuhairwe S; Faxelid E; Klingberg-Allvin M
    PLoS One; 2016; 11(2):e0149172. PubMed ID: 26872219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health system capacity for post-abortion care in Java, Indonesia: a signal functions analysis.
    Philbin J; Soeharno N; Giorgio M; Kurniawan R; Ingerick M; Utomo B
    Reprod Health; 2020 Nov; 17(1):189. PubMed ID: 33239059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting.
    Ngoc NT; Shochet T; Blum J; Hai PT; Dung DL; Nhan TT; Winikoff B
    BMC Pregnancy Childbirth; 2013 May; 13():118. PubMed ID: 23697561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical methods for first trimester abortion.
    Kulier R; Kapp N; Gülmezoglu AM; Hofmeyr GJ; Cheng L; Campana A
    Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD002855. PubMed ID: 22071804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second trimester abortions in India.
    Dalvie SS
    Reprod Health Matters; 2008 May; 16(31 Suppl):37-45. PubMed ID: 18772082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries.
    Shochet T; Diop A; Gaye A; Nayama M; Sall AB; Bukola F; Blandine T; Abiola OM; Dao B; Olayinka O; Winikoff B
    BMC Pregnancy Childbirth; 2012 Nov; 12():127. PubMed ID: 23150927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health workers' experience of providing second-trimester abortion care in Ethiopia: a qualitative study.
    McLean E; Blystad A; Mirkuzie AH; Miljeteig I
    Reprod Health; 2023 Oct; 20(1):154. PubMed ID: 37848942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies.
    Shochet T; Dragoman M; Blum J; Abbas D; Louie K; Platais I; Tsereteli T; Winikoff B
    Contraception; 2019 May; 99(5):288-292. PubMed ID: 30639446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morality versus duty - A qualitative study exploring midwives' perspectives on post-abortion care in Uganda.
    Cleeve A; Nalwadda G; Zadik T; Sterner K; Klingberg-Allvin M
    Midwifery; 2019 Oct; 77():71-77. PubMed ID: 31255911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal.
    Warriner IK; Wang D; Huong NT; Thapa K; Tamang A; Shah I; Baird DT; Meirik O
    Lancet; 2011 Apr; 377(9772):1155-61. PubMed ID: 21458058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
    Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
    Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doctors or mid-level providers for abortion.
    Barnard S; Kim C; Park MH; Ngo TD
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011242. PubMed ID: 26214844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy.
    Shah D; Rijal P; Thakur A; Rai R
    JNMA J Nepal Med Assoc; 2018; 56(213):856-860. PubMed ID: 31065120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.